Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
35.72M | 42.76M | 81.97M | 78.61M | 44.74M | Gross Profit |
11.20M | 4.71M | 32.66M | 37.44M | 16.10M | EBIT |
-19.58M | -28.64M | -6.54M | 4.09M | -13.39M | EBITDA |
-18.51M | -56.09M | -4.94M | 8.18M | -16.20M | Net Income Common Stockholders |
-22.36M | -61.06M | -6.05M | 4.22M | -22.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.90M | 2.94M | 5.00M | 25.98M | 18.77M | Total Assets |
24.96M | 37.17M | 108.75M | 91.20M | 79.58M | Total Debt |
5.17M | 9.54M | 18.35M | 3.19M | 9.53M | Net Debt |
2.27M | 6.59M | 13.35M | -22.79M | -9.23M | Total Liabilities |
22.61M | 27.41M | 54.51M | 27.48M | 22.17M | Stockholders Equity |
2.35M | 9.77M | 54.24M | 63.71M | 57.41M |
Cash Flow | Free Cash Flow | |||
-9.16M | -5.68M | -32.38M | 7.85M | -20.07M | Operating Cash Flow |
-9.12M | -2.56M | -26.45M | 9.82M | -13.69M | Investing Cash Flow |
-41.00K | -4.92M | -5.95M | -1.96M | -12.00M | Financing Cash Flow |
9.14M | 5.34M | 11.41M | -788.00K | 39.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $514.32M | 155.81 | 1.98% | ― | -13.88% | -80.31% | |
59 Neutral | $10.73B | 10.11 | -6.65% | 3.02% | 7.41% | -11.17% | |
55 Neutral | $176.66M | ― | -33.75% | ― | -11.19% | -174.51% | |
52 Neutral | AU$112.81M | ― | -5.63% | ― | -11.96% | 7.50% | |
34 Underperform | $541.09M | ― | -133.28% | ― | 72.47% | 20.08% | |
33 Underperform | $6.08M | ― | -363.56% | ― | -6.41% | 46.53% |
Atomos Limited has secured a $13.7 million debt facility with Monreii Pty Ltd, owned by its Executive Director, Peter Barber, to support its financial strategy and reach cashflow positivity by FY26. This facility, chosen for its minimal shareholder dilution and quick execution, will repay existing loans and support new product launches expected to boost sales in the coming quarters, positioning Atomos for improved financial health and shareholder value.
Atomos Limited has released its interim financial statements for the half-year ended 31 December 2024. The report provides insights into the company’s financial performance over the six-month period, highlighting key figures and changes in financial position. This release is crucial for stakeholders as it offers a detailed view of Atomos Limited’s financial health and operational efficiency, which can influence investor confidence and market positioning.
Atomos Limited reported a 7% increase in Q2 FY25 sales, driven largely by its Shinobi II product, despite a drop in gross profit margins due to discounting in response to competitive pressures. The company is undergoing restructuring with a focus on cost management and new product development aimed at engaging price-conscious consumers. While maintaining revenue levels, Atomos is working on expanding its low-end product suite to bolster sales, and expects its cost adjustments to reflect in the latter half of FY25. The funding review is underway with commitments from major shareholders, ensuring financial stability as the company navigates a challenging market environment.